Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

Lonial, Sagar; Lee, Hans C.; Badros, Ashraf; Trudel, Suzanne; Nooka, Ajay K.; Chari, Ajai; Abdallah, Al-Ola; Callander, Natalie; Lendvai, Nikoletta; Sborov, Douglas; Suvannasankha, Attaya; Weisel, Katja; Karlin, Lionel; Libby, Edward; Arnulf, Bertrand; Facon, Thierry; Hulin, Cyrille; Kortum, K. Martin; Rodriguez-Otero, Paula; Usmani, Saad Z.; Hari, Parameswaran; Baz, Rachid; Hang Quach; Moreau, Philippe; Voorhees, Peter M.; Gupta, Ira; Hoos, Axel; Zhi, Eric; Baron, January; Piontek, Trisha; Lewis, Eric; Jewell, Roxanne C.; Dettman, Elisha J.; Popat, Rakesh; Esposti, Simona Degli; Opalinska, Joanna; Richardson, Paul; Cohen, Adam D.

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

Author:

Lonial, Sagar; Lee, Hans C.; Badros, Ashraf; Trudel, Suzanne; Nooka, Ajay K.; Chari, Ajai; Abdallah, Al-Ola; Callander, Natalie; Lendvai, Nikoletta; Sborov, Douglas; Suvannasankha, Attaya; Weisel, Katja; Karlin, Lionel; Libby, Edward; Arnulf, Bertrand; Facon, Thierry; Hulin, Cyrille; Kortum, K. Martin; Rodriguez-Otero, Paula; Usmani, Saad Z.; Hari, Parameswaran; Baz, Rachid; Hang Quach; Moreau, Philippe; Voorhees, Peter M.; Gupta, Ira; Hoos, Axel; Zhi, Eric; Baron, January; Piontek, Trisha; Lewis, Eric; Jewell, Roxanne C.; Dettman, Elisha J.; Popat, Rakesh; Esposti, Simona Degli; Opalinska, Joanna; Richardson, Paul; Cohen, Adam D.

Tübinger Autor(en):

Weisel, Katja

Published in:

Lancet Oncology (2020), Bd. 21, H. 2, S. 207-221

Verlagsangabe:

Elsevier Science Inc

Language:

English

Full text:

http://dx.doi.org/10.1016/S1470-2045(19)30788-0

ISSN:

1474-5488